Sana Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-283.26	-269.48	-355.93	-285.31	-130.78	-13.25
Depreciation & Amortization	37.82	27.73	17.91	10.17	3.92	0
Share-Based Compensation	35.53	38.34	22.36	5.83	1.5	0.06
Other Operating Activities	-43.68	-86.64	64.6	131.32	39.84	-0.31
Operating Cash Flow	-253.58	-290.05	-251.05	-137.98	-85.52	-13.5
Capital Expenditures	-20.03	-20.88	-29.86	-23.87	-26.12	-0.46
Acquisitions	0	0	0	0	-3.2	0
Change in Investments	192.04	231.44	-211.36	-228.69	-58.54	-0.32
Other Investing Activities	-	-	-4.57	-	-	-
Investing Cash Flow	172.01	210.56	-245.8	-252.56	-87.86	-0.78
Share Issuance / Repurchase	31.65	4.91	631.75	0.15	0	0
Other Financing Activities	-	-	-	435.54	223.74	45.72
Financing Cash Flow	31.65	4.91	631.75	435.69	223.74	45.72
Net Cash Flow	-49.92	-74.58	134.9	45.14	50.36	31.45
Free Cash Flow	-273.61	-310.93	-280.92	-161.85	-111.64	-13.96
Free Cash Flow Per Share	-1.41	-1.65	-1.69	-12.44	-22.77	-14.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).